Ponatinib Hydrochloride (CAS 1114544-31-8)

« Back to Anti-Cancer API

Ponatinib Hydrochloride

CAS No. 1114544-31-8
盐酸泊那替尼
Ponatinib Hydrochloride structure
Chemical structure
CAS No.1114544-31-8
Synonyms3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
CategoryAnti-Cancer API / Anti-Cancer
Assay / Purity99%
Molecular FormulaC29H28ClF3N6O
Molecular Weight569.0
Melting Point—
Boiling Point—
Density—
Flash Point—
AppearancePale yellow to white solid powder

Application and positioning

Ponatinib hydrochloride is a third-generation BCR-ABL1 tyrosine kinase inhibitor with activity against the T315I gatekeeper mutation, supplied as the hydrochloride salt. It is used in oral tablets for chronic myeloid leukaemia and Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.

Quality and documentation

  • Batch-specific Certificate of Analysis issued by the manufacturing site
  • SDS/MSDS and specification sheet available on request
  • Residual solvents and elemental impurities statements discussed per project
  • For pharmaceutical manufacturing and R&D use only — not for direct administration

Packaging and handling

  • Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
  • Small quantities in sealed aluminium foil bags
  • Palletised for air and sea freight; store dry, ventilated and protected from light

Related products

Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.

Interested in this product?

Contact us for price, COA, MSDS and lead time — custom synthesis available.

Request a Quote

Reference: CAS 1114544-31-8 · PubChem CID 46908927